Performance Measures Related to Colposcopy for Canadian Cervical Cancer Screening Programs: Identifying Areas for Improvement Kathleen M. Decker, PhD, C. Meg McLachlin, MD, FRCPC, Robert Lotocki, MD, FRCPC Journal of Obstetrics and Gynaecology Canada Volume 37, Issue 3, Pages 245-251 (March 2015) DOI: 10.1016/S1701-2163(15)30310-8 Copyright © 2015 Society of Obstetricians and Gynaecologists of Canada Terms and Conditions
Figure 1 Percentage of women 20 to 69years of age who had an ASC-H, HSIL, or more severe Pap test result, colposcopy, and a biopsy within 12months of the Pap test by province (2009 and 2010) HSIL or more severe: high-grade squamous intraepithelial lesions, carcinoma in situ, and invasive carcinoma; NS: Nova Scotia; AB: Alberta; BC: British Columbia; MB: Manitoba. Journal of Obstetrics and Gynaecology Canada 2015 37, 245-251DOI: (10.1016/S1701-2163(15)30310-8) Copyright © 2015 Society of Obstetricians and Gynaecologists of Canada Terms and Conditions
Figure 2 Percentage of women 20 to 69years of age who had an ASC-H or HSIL or more severe Pap test result with histological work-up and who had a pre-cancerous or cancerous lesion (CIN 2 and CIN 3+) in the 12months after the Pap test by province HSIL+: high-grade squamous intraepithelial lesions, carcinoma in situ, and invasive carcinoma; BC: British Columbia; PE: Prince Edward Island; NS: Nova Scotia; AB: Alberta; MB: Manitoba. Journal of Obstetrics and Gynaecology Canada 2015 37, 245-251DOI: (10.1016/S1701-2163(15)30310-8) Copyright © 2015 Society of Obstetricians and Gynaecologists of Canada Terms and Conditions